Avid Bioservices Inc (CDMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2013 | 04-2013 | 01-2013 | 10-2012 | 07-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,600 | -29,780 | -21,331 | -16,417 | -7,664 |
| Depreciation Amortization | 257 | 1,087 | 806 | 526 | 260 |
| Accounts receivable | -610 | 691 | 370 | 33 | 82 |
| Accounts payable and accrued liabilities | -661 | -691 | -1,883 | -316 | 621 |
| Other Working Capital | -2,374 | 2,628 | 291 | 3,246 | 6,641 |
| Other Operating Activity | 2,864 | 5,139 | 5,537 | 3,270 | -41 |
| Operating Cash Flow | $-8,124 | $-20,926 | $-16,210 | $-9,658 | $-101 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | -853 | -686 | -309 | -190 |
| Other Investing Activity | -223 | 102 | -55 | -201 | -175 |
| Investing Cash Flow | $-250 | $-751 | $-741 | $-510 | $-365 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 14,749 | 14,749 | 14,749 | N/A |
| Debt Repayment | -20 | -15,078 | -15,058 | -15,039 | -19 |
| Common Stock Issued | 14,790 | 40,152 | 26,457 | 17,843 | 1,443 |
| Other Financing Activity | 0 | -975 | -975 | -975 | 0 |
| Financing Cash Flow | $14,770 | $38,848 | $25,173 | $16,578 | $1,424 |
| Beginning Cash Position | 35,204 | 18,033 | 18,033 | 18,033 | 18,033 |
| End Cash Position | 41,600 | 35,204 | 26,255 | 24,443 | 18,991 |
| Net Cash Flow | $6,396 | $17,171 | $8,222 | $6,410 | $958 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,124 | -20,926 | -16,210 | -9,658 | -101 |
| Capital Expenditure | -27 | -853 | -686 | -309 | -190 |
| Free Cash Flow | -8,151 | -21,779 | -16,896 | -9,967 | -291 |